Dementia Australia welcomes UK approval of lecanemab to tackle Alzheimer’s

Post author:
Post published:August 27, 2024
Post category:uncategorized

Dementia Australia welcomes the decision by the Medicines and Healthcare Products Regulatory Agency to approve Lecanemab for use in the UK.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Protective genetic variant shields Black Americans from kidney disease risk

AI models boost detection of cognitive decline in medical records, study finds

Taletrectinib shows high response rates and safety in ROS1+ lung cancer patients

Helpful Links

Subscribe To Us